Brickell Biotech, Inc. carries a market capitalization of 7.08M, placing it among publicly traded companies globally.
| Market Cap | 7.08M |
| Enterprise Value | N/A |
Brickell Biotech, Inc.'s stock has declined approximately -76.89282% over the past 52 weeks.
| Beta (5Y) | N/A |
| 52-Week Price Change | -76.89282% |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
| Average Volume (20 Days) | N/A |
Brickell Biotech, Inc.'s most recent stock split took place on July 5, 2022 with a 45:1 split ratio.
| Last Split Date | 7/5/2022 |
| Split Ratio | 45:1 |